• Thapsigargin for Calcium and ER Stress Workflows

  2026-09-26

  Use Thapsigargin to create a rapid, controllable SERCA-dependent calcium perturbation, then connect that response to ER stress and cell-fate readouts. This workflow guide shows how to pair calcium imaging with reporter and viability assays while distinguishing direct tool-compound effects from pathway-selective findings.

• circ0043898 Suppresses Stemness in Esophageal Cancer

  2026-09-25

  Wang and colleagues report that circ0043898 overexpression reduces stem-cell-associated markers and sphere formation in esophageal cancer cells, alongside changes in PI3K-associated readouts and KRAS expression. A KRAS co-expression experiment partially counteracted these effects, supporting a functional relationship between KRAS and circ0043898-regulated stemness while leaving the precise molecular mechanism and clinical relevance to be established.

• Thapsigargin Workflows for Calcium and ER Stress

  2026-09-25

  Use Thapsigargin to separate rapid ER calcium-store depletion from downstream stress and cell-death responses. This practical guide connects calcium imaging and apoptosis assays to a pulmonary inflammation study, with staged dosing, controls, and troubleshooting to improve interpretation.

• How Near-Death Tumor Cells Acquire Metastatic States

  2026-09-24

  Conod and colleagues report that tumor cells rescued from impending death can acquire stable prometastatic properties, which they termed PAMEs. Their findings connect ER stress and cellular reprogramming with a local cytokine-driven interaction that recruits migratory neighboring cells, suggesting a route by which cell-death stress may shape metastatic behavior.

• Deferasirox Fe3+ chelate in Cell Assays

  2026-09-24

  A practical guide to interpreting iron-related cell assay results and handling Deferasirox Fe3+ chelate (SKU A3355). It distinguishes the ferric complex from uncomplexed deferasirox and connects appropriate workflow controls with current research on glucose starvation and lysosomal cell death.

• Thapsigargin: SERCA Pump Inhibitor for ER Research

  2026-09-23

  Thapsigargin is a potent SERCA pump inhibitor used to perturb ER calcium storage and investigate calcium signaling, ER stress, and apoptosis. Product information reports subnanomolar inhibition of carbachol-induced calcium transients, while assay-specific conditions should be confirmed before reproducing that benchmark.

• Streptavidin Magnetic Beads for HBV Entry Studies

  2026-09-23

  Benzyl-activated Streptavidin Magnetic Beads provide a practical bridge between biotinylated molecule capture and mechanistic HBV entry research. This article explains how K1301 can support assays that distinguish NTCP trafficking, Rab11-dependent recycling, clathrin-mediated endocytosis, and CDC42-linked macropinocytosis.

• RSL3: Glutathione Peroxidase 4 Inhibitor Workflows

  2026-09-22

  RSL3 provides a direct GPX4-on switch for ferroptosis experiments, helping researchers separate lipid-peroxide execution from upstream redox effects. This workflow connects dose-response design, rescue controls, membrane-failure readouts, oncogenic RAS synthetic lethality, and the 2025 TMEM16F finding without treating one viability assay as proof of mechanism.

• Triiodothyronine (T3) in Cell Assays

  2026-09-22

  Learn how Triiodothyronine (T3, SKU C6407) can improve experimental control in cell viability, proliferation, cytotoxicity, and metabolic assays. This scenario-based guide covers solubility, storage, assay interpretation, orthogonal endpoints, and practical vendor-selection criteria.

• Puromycin aminonucleoside: Podocyte Injury Workflows

  2026-09-21

  Build reproducible podocyte injury, proteinuria, and glomerular lesion studies with Puromycin aminonucleoside while separating validated product data from workflow recommendations. A practical bridge to aggregation-sensitive proteomics also shows how renal injury phenotypes could be paired with deeper molecular target discovery.

• SB743921: Measuring KSP-Driven Cancer Responses

  2026-09-21

  SB743921 is a highly selective kinesin spindle protein inhibitor for dissecting mitotic arrest, growth inhibition, and cell death. This article translates mechanistic potency into time-resolved assay decisions, building on cancer-response methodology to improve interpretation in vitro and in tumor xenograft models.

• AMPK–SQSTM1 Feedback Under Metabolic Stress

  2026-09-20

  This 2024 AUTOPHAGY study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that coordinates NRF2 antioxidant signaling with energy-stress adaptation. Its findings connect lysosomal pH, calcium release, ROS, TFEB/TFE3, and TAK1 to a mechanism that may help explain metabolic resilience in STK11- and KEAP1-altered lung cancer.

• Deferiprone: Iron Chelation Research Workflows

  2026-09-19

  Deferiprone enables controlled iron depletion for cancer biology, oxidative-stress, apoptosis, and tissue-injury studies. This workflow-focused guide connects cell assays with findings from a sickle cell kidney injury model while emphasizing solvent choice, timing, orthogonal readouts, and troubleshooting.

• Linagliptin (BI-1356): A Translational Assay Guide

  2026-09-18

  Linagliptin (BI-1356) is a DPP-4 inhibitor whose assay interpretation must be kept distinct from NUAK-directed tau research. This guide explains how the Taylor et al. brain-slice study informs rigorous comparator selection, phospho-tau readouts, and cross-domain experimental design.

• Sodium Picosulfate in Gut–Liver–Brain Assays

  2026-09-18

  Sodium Picosulfate is examined here as a controllable intestinal physiology variable—not as an unproven hepatic encephalopathy therapy. The article translates regional [18F]PBR146 PET findings into practical decisions for gut–liver–brain assay design, controls, and interpretation.

549 records 3/37 page Previous Next 12345 下5页 Last page